Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results.

scientific article published on 12 December 2008

Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10545-008-1000-0
P698PubMed publication ID19067231
P5875ResearchGate publication ID23642575

P2093author name stringH M Mirghani
M A Hamdan
M H Almalik
P2860cites workRecombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe diseaseQ28277595
Antenatal diagnosis of heart diseaseQ33839214
Update of the Pompe disease mutation database with 107 sequence variants and a format for severity ratingQ34011226
Pompe disease diagnosis and management guideline.Q34567528
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literatureQ35191008
Evolution and long term outcome in cases with fetal diagnosis of congenital heart disease: Italian multicentre study. Fetal Cardiology Study Group of the Italian Society of Pediatric CardiologyQ35566677
Mid-trimester genetic amniocentesis in twin pregnancy and the risk of fetal loss.Q36542140
Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndromeQ40325048
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe diseaseQ44312356
Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcomeQ46350966
Electrocardiographic response to enzyme replacement therapy for Pompe disease.Q51807688
Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.Q51876865
Electron Microscopy of Chorionic Villus Samples for Prenatal Diagnosis of Lysosomal Storage DisordersQ57522858
Rapid Prenatal Diagnosis of Glycogen-Storage Disease Type II by Electron Microscopy of Uncultured Amniotic-Fluid CellsQ70334263
Prenatal diagnosis of glycogen storage disease type II: enzyme assay or mutation analysis?Q71527630
Hypertrophic cardiomyopathy in a newborn infantQ77765269
Prenatal diagnosis of Pompe disease by electron microscopyQ80094302
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective studyQ80492903
Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experienceQ80797568
P921main subjectenzyme replacement therapyQ916766
P304page(s)S431-6
P577publication date2008-12-12
P1433published inJournal of Inherited Metabolic DiseaseQ6295359
P1476titleEarly administration of enzyme replacement therapy for Pompe disease: short-term follow-up results.
P478volume31 Suppl 2

Reverse relations

cites work (P2860)
Q40413861Alkaptonuria and Pompe disease in one patient: metabolic and molecular analysis
Q84989744Antenatal diagnosis of pompe disease by fetal echocardiography: impact on outcome after early initiation of enzyme replacement therapy
Q43160797Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glycogenosis
Q43948150Enzyme replacement in neuronal storage disorders in the pediatric population
Q37976643Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations.
Q61063601Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report
Q37741152Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE).
Q35752654Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience
Q30499512Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.
Q38615407Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy
Q39616879Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes.
Q36590894The Changing Face of Infantile Pompe Disease: A Report of Five Patients from the UAE

Search more.